Health
‘Another agent in our arsenal’: Finerenone benefits extend to those with, without CVD – Healio
Among adults with chronic kidney disease and type 2 diabetes, the mineralocorticoid receptor inhibitor antagonist finerenone reduced the incidence of CV events…
Source/Disclosures
Source: Filippatos G, et al. LBS.07: Randomized trials — brain, kidney and heart. Presented at: American Heart Association Scientific Sessions; Nov. 13-17, 2020 (virtual meeting).
Disclosures:
Filippatos reports he receives lecture or advisory board fees from Amgen, Bayer, Boehringer Ingelheim, Medtronic, Novartis, Servier and Vifor. Wanner reports he receives lecture or advisory fees from AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, FMC, Gilead, GlaxoSmithKline and…
-
Noosa News15 hours agoKatter and pregnant wife crash-land plane in outback Qld
-
Business22 hours agoprofit up 7%, guidance strong
-
Noosa News15 hours agoFollowing Up Hottest 100 of Australian Songs Success with a Second Documentary About Your Life and Career: Jimmy Barnes Talks ‘Working Class Man’
-
Noosa News19 hours agoItalian Film Festival, Brisbane: All the Details